cerrar
Tagged with P

China: New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug expenditures in 2018, the world’s…

Funding the Cell & Gene Therapy Boom
The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the history of the pharmaceuticals…

RWE: Unlocking the Full Potential of Cell & Gene
Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems: carrying the potential to offer…

Top 15 Pharma Companies in Central America & Caribbean
The Top 15 pharma companies in the Central America & Caribbean (CENCA) region's retail market (Rx & OTC) for 2019 ranked by sales in USD…

Navigating the Increasingly Stormy Waters of US Market Access 
Certara's Ulrich Neumann examines some of the major US market access trends of the past few years, including the innovative financing models required…

Chris Martin – CEO, Co-Founder and Director, ADC…
Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC Therapeutics, shares the company’s journey…

Vincent Ruland – Country Division Head, Bayer…
Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the company’s priorities in Malaysia,…

Michael Quirmbach – CEO & President, CordenPharma
The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing industry, explaining the reasons behind the…

EUnetHTA’s Uncertain Future & the Evolution of…
The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European…

Jean-Paul Clozel – CEO, Idorsia
In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

Pharma Country Managers: The COVID Generation
While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here